Occupation and Community Exposure to AMR in Dumpsites open_dumpsite Open dumpsite (Municipal Solid Waste dumpsite) controlled_dumpsite Controlled dumpsite sanitary_dumpsite Sanitary dumpsite open_burning_dumpsite Open burning dumpsite informal_community_dumpsite Informal/community dumpsite industrial_hazardous_waste_dumpsite Industrial/hazardous waste dumpsite other Other human_health_alone Human health alone human_animal_health Human-Animal health human_animal_environment_health Human-Animal-Environment health stool Stool rectal_swab Rectal swab urine Urine blood Blood nasal_swab Nasal swab throat_swab Throat/oropharyngeal swab wound_swab wounds swab skin_swab Skin swab sputum Sputum other Other g_positive Gram-positive g_negative Gram-negative genotypic Genotypic phenotypic Phenotypic multi_drug_resistance Multidrug resistance (at least 1 agents in >=3 different classes) pan_drug_resistance Pandrug-resistant (all vailable classes) extensive_drug_resistance Extensively drug-resistant (Almost all, exept 1/2 classes) difficult_to_treat_resistance Difficult-to-treat resistance (all first-line) not_applicable Not Applicable other Other male Male female Female not_mentioned Not mentioned neonates Neonates children Children adults Adults urban Urban periurban Peri-urban rural Rural random Random convenience Convenience purposive Purposive stratified Stratified not_mentioned Not mentioned other Other resistant Resistant susceptible Susceptible clsi CLSI eucast EUCAST not_mentioned Not mentioned other Other 1. First author name e.g., lusanji et al not Lusanji et al 2. Study DOI if information re the study is missing, this will be used 3. Year of publication 4. Country/s where the study was conducted Benin benin Burkina Faso burkina_faso Cabo Verde cabo_verde Côte d'Ivoire cote_divoire Gambia gambia Ghana ghana Guinea guinea Guinea-Bissau guinea_bissau Liberia liberia Mali mali Mauritania mauritania Niger niger Nigeria nigeria Senegal senegal Sierra Leone sierra_leone Togo togo Cameroon cameroon Central African Republic central_african_republic Chad chad Republic of the Congo republic_of_the_congo Democratic Republic of the Congo democratic_republic_of_the_congo Equatorial Guinea equatorial_guinea Gabon gabon São Tomé and Príncipe são_tomé_and_príncipe Burundi burundi Comoros comoros Djibouti djibouti Eritrea eritrea Ethiopia ethiopia Kenya kenya Madagascar madagascar Malawi malawi Mauritius mauritius Mozambique mozambique Rwanda rwanda Seychelles seychelles Somalia somalia South Sudan south_sudan Tanzania tanzania Uganda uganda Zambia zambia Zimbabwe zimbabwe Angola angola Botswana botswana Eswatini eswatini Lesotho lesotho Namibia namibia South Africa south_africa Other other Specify other. 5a. Study setting 5b. Study design Cross-sectional survey cross_sectional_survey Cross-sectional analytical cross_sectional_analytical Case-control studies case_control Cohort studies cohort_studies Randomized Controlled Trials randomised_control_trials Non-randomized trials non_randomised_trials Ethnography studies ethnography_studies Other other Specify other. 5c. Sampling strategy Specify other. 6. Dumpsite type Specify other. 7. One Health domain combination studied 8. Exposure type Contact with waste-contaminated soil contact_with_waste_contaminated_soil Contact with waste-contaminated water contact_with_waste_contaminated_water Inhalation of bioaerosols from decomposing waste inhalation_of_bioaerosols_from_decomposing_waste Sorting, collecting, or transporting mixed municipal waste sorting_collecting_or_transporting_mixed_municipal_waste Cuts or needle-stick injuries from sharps-contaminated waste cuts_or_needle_injuries_from__sharps_contaminated_waste Exposure to smoke containing resistant bacteria and genetic material exposure_to_smoke_containg_resistant_bacteria_and_genetic_material Consumption of contaminated food consumption_of_contaminated_food Contact with stray animals contact_with_stray_animals Own livestock grazing on dumpsites own_livestock_grazing_on_dumpsites Lack of protective equipment lack_of_protective_equipment Living in makeshift shelters within dumpsite zones living_in_makeshift_within_dumpsite_zones Other other Specify other. 9. Specimen type Specify other. 10. Bacterial group studied 11. Quality control strains used write in uppercase e.g., Escherichia coli ATCC 25922 12a. Specific Gram-positive bacterial species studied Staphylococcus aureus staphylococcus_aureus Staphylococcus epidermidis staphylococcus_epidermidis Enterococcus faecalis enterococcus_faecalis Enterococcus faecium enterococcus_faecium Streptococcus pneumoniae streptococcus_pneumoniae Streptococcus pyogenes streptococcus_pyogenes Streptococcus agalactiae streptococcus_agalactiae Clostridioides difficile clostridioides_difficile Bacillus cereus bacillus_cereus Listeria monocytogenes listeria_monocytogenes Corynebacterium diphtheriae corynebacterium_diphtheriae Clostridium perfringens clostridium_perfringens Enterococcus spp enterococcus_spp Bacillus spp bacillus_spp Streptococcus spp streptococcus_spp Staphylococcus spp staphylococcus_spp Other other Specify other. 12b. Specific Gram-negative bacterial species studied Escherichia coli escherichia_coli Klebsiella pneumoniae klebsiella_pneumoniae Salmonella enterica salmonella_enterica Shigella spp shigella_spp Proteus mirabilis proteus_mirabilis Enterobacter cloacae enterobacter_cloacae Citrobacter freundii citrobacter_freundii Serratia marcescens serratia_marcescens Pseudomonas aeruginosa pseudomonas_aeruginosa Acinetobacter baumannii acinetobacter_baumannii Stenotrophomonas maltophilia stenotrophomonas_maltophilia Vibrio cholerae vibrio_cholerae Aeromonas hydrophila aeromonas_hydrophila Haemophilus influenzae haemophilus_influenzae Neisseria gonorrhoeae neisseria_gonorrhoeae Campylobacter jejuni campylobacter_jejuni Salmonella spp salmonella_spp Klebsiella spp klebsiella_spp Enterobacter spp enterobacter_spp Citrobacter spp citrobacter_spp Campylobacter spp campylobacter_spp Other other Specify other. 13. Species characterization of resistance 14. Resistance outcomes reported If any resistance has been reported 15a. Phenotypic Method used for characterization of resistance Kirby–Bauer disc diffusion test kirby_bauer_disk_diffusion_test Broth microdilution (for Minimum Inhibitory Concentration) broth_microdilution Agar dilution agar_dilution E-test e_test VITEK 2 vitek_avitek_2 BD Phoenix bd_aphoenix MicroScan WalkAway microscan_aalkaway Microtiter plate crystal violet assay (for biofilm) microtiter_plate_crystal_violate_assay Other other Specify other. 15b. Genotypic Method used for characterization of resistance Conventional PCR (singleplex PCR) conventional_pcr Multiplex PCR multiplex_pcr Real-time PCR (qPCR) real_time_pcr Reverse transcription PCR reverse_transcription_pct Allele-specific PCR allele_specific_pcr Sanger sequencing sanger_sequencing Whole Genome Sequencing whole_genome_sequencing CRISPR-Cas assays crispr_cas_assays Shotgun metagenomic sequencing shortgun_metagenomic_sequencing Other other Specify other. 16. Interpretation guideline for resistance used Specify other. 17. Resistance type reported Specify other. 18. Class of antimicrobial agents the bacteria is resistant against Beta lactams (Penicillins - Amoxicillin; Cephalosporins - Cefepime, Ceftriaxone; Carbapenems - Meropenem; Monobactams - Aztreonam) beta_lactams Aminoglycosides (Gentamicin, Amikacin, Streptomycin) aminoglycosides Macrolides (Azithromycin, Erythromycin, Clarithromycin) macrolides Tetracyclines (Tetracycline, Doxycycline, Minocycline) tetracyclines Fluoroquinolones (Ciprofloxacin, Levofloxacin, Ofloxacin, Moxifloxacin) fluoroquinolones Sulfonamides (Sulfamethoxazole + Trimethoprim, Sulfadiazine) sulfonamides Glycopeptides (Vancomycin, Teicoplanin) glycopeptides Lincosamides (Clindamycin, Lincomycin) lincosamides Oxazolidinones (Linezolid, Tedizolid) oxazolidinones Nitroimidazoles (Metronidazole, Tinidazole) nitroimidazoles Rifamycins (Rifampicin, Rifabutin) rifamycins Polypeptides (Bacitracin, Polymixin B, Colistin - Polymyxin E) polypeptides Cloramphenicol (Chloramphenicol) cloramphenicol Miscellaneous (Fosfomycin, Nitrofurantoin, Mupirocin) miscellaneous Other other Specify other. 19. Gender of the study population 20. Age group of the study population